Roche Defends Accutane Against New Evidence In NJ Retrial
Hoffman-LaRoche Inc. on Friday urged a New Jersey jury to reject claims its drug Accutane causes inflammatory bowel disease, summating a case that was buttressed by new scientific evidence following an...To view the full article, register now.
Already a subscriber? Click here to view full article